rs7614776

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001039770.3(TMPPE):​c.-442T>C variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.889 in 1,612,206 control chromosomes in the GnomAD database, including 638,460 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.89 ( 60318 hom., cov: 38)
Exomes 𝑓: 0.89 ( 578142 hom. )

Consequence

TMPPE
NM_001039770.3 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:18O:1

Conservation

PhyloP100: 0.792

Publications

23 publications found
Variant links:
Genes affected
TMPPE (HGNC:33865): (transmembrane protein with metallophosphoesterase domain) Predicted to enable hydrolase activity and metal ion binding activity. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
GLB1 (HGNC:4298): (galactosidase beta 1) This gene encodes a member of the glycosyl hydrolase 35 family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature lysosomal enzyme. This enzyme catalyzes the hydrolysis of a terminal beta-linked galactose residue from ganglioside substrates and other glycoconjugates. Mutations in this gene may result in GM1-gangliosidosis and Morquio B syndrome. [provided by RefSeq, Nov 2015]
GLB1 Gene-Disease associations (from GenCC):
  • GM1 gangliosidosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Myriad Women’s Health
  • GM1 gangliosidosis type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • mucopolysaccharidosis type 4B
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • GM1 gangliosidosis type 1
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • GM1 gangliosidosis type 2
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 3-33097052-A-G is Benign according to our data. Variant chr3-33097052-A-G is described in ClinVar as Benign. ClinVar VariationId is 92905.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.977 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001039770.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TMPPE
NM_001039770.3
MANE Select
c.-442T>C
5_prime_UTR_premature_start_codon_gain
Exon 1 of 2NP_001034859.2Q6ZT21-1
GLB1
NM_000404.4
MANE Select
c.34T>Cp.Leu12Leu
synonymous
Exon 1 of 16NP_000395.3
TMPPE
NM_001039770.3
MANE Select
c.-442T>C
5_prime_UTR
Exon 1 of 2NP_001034859.2Q6ZT21-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TMPPE
ENST00000342462.5
TSL:2 MANE Select
c.-442T>C
5_prime_UTR_premature_start_codon_gain
Exon 1 of 2ENSP00000343398.4Q6ZT21-1
GLB1
ENST00000307363.10
TSL:1 MANE Select
c.34T>Cp.Leu12Leu
synonymous
Exon 1 of 16ENSP00000306920.4P16278
GLB1
ENST00000307377.12
TSL:1
c.34T>Cp.Leu12Leu
synonymous
Exon 1 of 13ENSP00000305920.8E7EQ29

Frequencies

GnomAD3 genomes
AF:
0.889
AC:
135240
AN:
152122
Hom.:
60287
Cov.:
38
show subpopulations
Gnomad AFR
AF:
0.866
Gnomad AMI
AF:
0.921
Gnomad AMR
AF:
0.944
Gnomad ASJ
AF:
0.908
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.949
Gnomad FIN
AF:
0.873
Gnomad MID
AF:
0.959
Gnomad NFE
AF:
0.879
Gnomad OTH
AF:
0.906
GnomAD2 exomes
AF:
0.909
AC:
222982
AN:
245356
AF XY:
0.910
show subpopulations
Gnomad AFR exome
AF:
0.866
Gnomad AMR exome
AF:
0.959
Gnomad ASJ exome
AF:
0.913
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
0.871
Gnomad NFE exome
AF:
0.879
Gnomad OTH exome
AF:
0.908
GnomAD4 exome
AF:
0.889
AC:
1298544
AN:
1459976
Hom.:
578142
Cov.:
94
AF XY:
0.891
AC XY:
647051
AN XY:
726342
show subpopulations
African (AFR)
AF:
0.862
AC:
28725
AN:
33338
American (AMR)
AF:
0.956
AC:
42601
AN:
44554
Ashkenazi Jewish (ASJ)
AF:
0.911
AC:
23732
AN:
26046
East Asian (EAS)
AF:
1.00
AC:
39590
AN:
39602
South Asian (SAS)
AF:
0.952
AC:
81898
AN:
86052
European-Finnish (FIN)
AF:
0.871
AC:
46496
AN:
53382
Middle Eastern (MID)
AF:
0.959
AC:
5522
AN:
5758
European-Non Finnish (NFE)
AF:
0.879
AC:
975989
AN:
1110934
Other (OTH)
AF:
0.895
AC:
53991
AN:
60310
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
9310
18620
27930
37240
46550
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21364
42728
64092
85456
106820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.889
AC:
135320
AN:
152230
Hom.:
60318
Cov.:
38
AF XY:
0.892
AC XY:
66418
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.865
AC:
35961
AN:
41566
American (AMR)
AF:
0.944
AC:
14439
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.908
AC:
3151
AN:
3472
East Asian (EAS)
AF:
0.999
AC:
5167
AN:
5170
South Asian (SAS)
AF:
0.949
AC:
4586
AN:
4834
European-Finnish (FIN)
AF:
0.873
AC:
9263
AN:
10610
Middle Eastern (MID)
AF:
0.959
AC:
280
AN:
292
European-Non Finnish (NFE)
AF:
0.879
AC:
59715
AN:
67962
Other (OTH)
AF:
0.907
AC:
1918
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
809
1617
2426
3234
4043
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
900
1800
2700
3600
4500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.882
Hom.:
32048
Bravo
AF:
0.894
Asia WGS
AF:
0.968
AC:
3360
AN:
3472

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
3
Mucopolysaccharidosis, MPS-IV-B (3)
-
-
3
not provided (3)
-
-
2
Infantile GM1 gangliosidosis (2)
-
-
1
GM1 gangliosidosis (2)
-
-
1
GM1 gangliosidosis type 2 (1)
-
-
1
GM1 gangliosidosis type 3 (1)
-
-
1
GM1 gangliosidosis;C0086652:Mucopolysaccharidosis, MPS-IV-B (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
6.5
DANN
Benign
0.65
PhyloP100
0.79
PromoterAI
-0.019
Neutral
RBP_binding_hub_radar
0.97
RBP_regulation_power_radar
2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7614776; hg19: chr3-33138544; COSMIC: COSV56561114; COSMIC: COSV56561114; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.